Name | Title | Contact Details |
---|---|---|
Mark Hoffmann |
Chief Information Officer | Profile |
Galera Therapeutics, Inc. is a private clinical-stage biotech company focused on the development of breakthrough drugs targeting the oxygen metabolic pathways. Located in the Greater Philadelphia area on the Route 202 High-Tech Corridor, Galera lead technology comprises a portfolio of small molecule superoxide dismutase mimetics that have broad therapeutic applicability. Superoxide, a product of normal cellular oxygen metabolism and certain environmental stresses, is harmful to DNA, RNA, proteins and lipids. This highly reactive molecule is normally managed by one of three superoxide dismutases (SOD1, 2 and 3), but the SOD enzymes are deficient or can be overwhelmed in certain disease states. Galera small molecule dismutase mimetics closely mimic the activity of the human superoxide dismutase enzymes and overcome this deficiency. While the biology of the superoxide dismutase family suggests a broad range of potential applications, Galera is initially focusing its development on the prevention of radiation-induced toxicity, including mucositis, and the treatment of cancer.
Auxilium is a fully integrated specialty biopharmaceutical company focused on developing and marketing products to predominantly specialist audiences. Auxilium means “assistance” in Latin, and that’s a fitting description for all of our biopharmaceutical development and commercialization efforts. Although we are living in an era of rapid advances in medical technology, many of society’s medical concerns remain unaddressed. Auxilium works to address some of these unmet needs. By doing so, we work in important areas of the pharmaceutical industry that require forward thinking and novel solutions that promote better health and living. Through advancement and expansion, Auxilium is dedicated to providing innovative solutions for underserved diseases that improve health and quality of life.
Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products. We specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Akorn has Research and Development facilities in Vernon Hills, IL; Copiague, NY and Warminster, PA that provide a robust and continuous pipeline of new products. Akorn`s manufacturing facilities are located in Amityville, NY; Decatur, IL; Hettlingen, Switzerland, Paonta Sahib, India; and Somerset, NJ.
Fruth Pharmacy has been serving Southwestern West Virginia and Southern Ohio Since 1952. We cater to the needs of our customers by providing the best customer service in town. Fruth's pharmacists are on duty 7 days a week and are dedicated to serving
TRx Pharma is a Chapel Hill, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.